Proof of concept for the reduction of classical swine fever infection in pigs by a novel viral polymerase inhibitor
- 1 June 2009
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 90 (6), 1335-1342
- https://doi.org/10.1099/vir.0.008839-0
Abstract
5-[(4-Bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP) is a representative of a class of imidazopyridines with potentin vitroantiviral activity against pestiviruses including classical swine fever virus (CSFV). This study analysed whether the lead compound, BPIP, was able to reduce virus replication in infected piglets. The compound, administered in feed, was readily bioavailable and was well tolerated. Eight specific-pathogen-free pigs received a daily dose of 75 mg kg−1(mixed in feed) for a period of 15 consecutive days, starting 1 day before infection with the CSFV field isolate Wingene. BPIP-treated pigs developed a short, transient viraemia (one animal remained negative) and leukopenia (three animals did not develop leukopenia). Virus titres at peak viraemia (7 days post-infection) were markedly lower (∼1000-fold) than in untreated animals (P=0.00005) and the viral genome load in blood was also significantly lower (P≤0.001) in drug-treated animals than in untreated animals over the entire experiment. At the end of the experiment (day 33), no infectious virus was detectable in the tonsils of BPIP-treated animals, although low levels of viral RNA were detected. The inability to isolate infectious virus from the tonsils indicates that the risk of a persistent CSFV infection is negligible. Further optimization of the antiviral potency and bioavailability of this lead compound may result in molecules completely suppressing virus replication. A potent antiviral could potentially be used as a primary control measure against virus spread in case of an outbreak, in addition to present countermeasures. This study provides the first proof of concept for the prophylaxis/treatment of CSFV infection in pigs.This publication has 28 references indexed in Scilit:
- Imidazo[4,5-c]pyridines inhibit the in vitro replication of the classical swine fever virus and target the viral polymeraseAntiviral Research, 2008
- Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccineVeterinary Microbiology, 2007
- Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: From anti-pestivirus to anti-hepatitis C virus activityBioorganic & Medicinal Chemistry Letters, 2007
- Substituted 5-benzyl-2-phenyl-5H-imidazo[4,5-c]pyridines: A new class of pestivirus inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- A Novel, Highly Selective Inhibitor of Pestivirus Replication That Targets the Viral RNA-Dependent RNA PolymeraseJournal of Virology, 2006
- Development of novel strategies to control foot-and-mouth disease: Marker vaccines and antiviralsBiologicals, 2005
- Evaluation of the epidemiological importance of classical swine fever infected, E2 sub-unit marker vaccinated animals with RT-nPCR positive blood samplesJournal of Veterinary Medicine, Series B, 2005
- Efficacy of the classical swine fever (CSF) marker vaccine Porcilis® Pesti in pregnant sowsVeterinary Microbiology, 2000
- Classical swine fever virus: a second ring test to evaluate RT-PCR detection methodsVeterinary Microbiology, 2000
- The 1997–1998 epidemic of classical swine fever in the NetherlandsVeterinary Microbiology, 2000